Verfahren zur Schätzung des Faktors von Blutgerinnungsanomalien
Anmelder: Sekisui Medical Co., Ltd., Public University Corporation Nara Medical University 🇯🇵
Details
- Veröffentlichungs-Nr.
- EP4790422
- Anmeldetag
- 3. Oktober 2024
- Veröffentlichung
- 10. April 2025
- Rechtsraum
- EP
- IPC
- G01N33/86
Abstract
Provided is a method for estimating a cause of coagulation disorders in a blood specimen. The method comprises 1) calculating a parameter Ps related to a coagulation reaction of a specimen S, and a parameter Pm related to a coagulation reaction of a specimen M; 2) estimating whether the specimen S is coagulation factor inhibitor-positive based on Ps; and 3) estimating that the specimen S which has not been estimated to be coagulation factor inhibitor-positive in 2) is lupus anticoagulant-positive or coagulation factor-deficient based on Pm or based on Ps and Pm. The specimen S is a subject blood specimen with a prolonged coagulation time, the specimen M is a mixed specimen of the specimen S and a specimen N, and the specimen N is a normal blood specimen. Ps is calculated based on a measurement point or time at which a coagulation reaction curve or coagulation rate curve of the specimen S reaches a predetermined value, and Pm is calculated based on a measurement point or time at which a coagulation reaction curve or coagulation rate curve of the specimen M reaches a predetermined value.
Anmelder
- Firmen
- Sekisui Medical Co., Ltd.
Public University Corporation Nara Medical University - Land
- 🇯🇵 Japan
Sekisui Medical ist eine japanische Tochtergesellschaft des Sekisui-Chemical-Konzerns, spezialisiert auf klinische Diagnostik und Labortechnik. Das Patentportfolio konzentriert sich sehr stark auf Mess-, Prüf- und Zeitmesstechnik sowie Pharma und Biotechnologie. Anmeldungen reichen von 2001 bis in die Gegenwart.
408 Patente in unserer Datenbank